Shares of Gilead Sciences Inc rose 6per cent on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United States.
Gilead shares rise after United States approves remdesivir as COVID-19 drug
- Advertisement -
Most Popular
Corporate issuance poses headwinds for Malaysian sovereign bonds
Ringgit swaps are now pricing eight basis points of easing over the next six months, from as much as 20 basis points...
Asian markets mixed after US Fed rate cut
The US Federal Reserve cut interest rates by a quarter of a percentage point and indicated it will steadily lower borrowing costs for the rest...
US SEC paves way for crypto spot ETFs with new listing rules
THE Securities and Exchange Commission voted on Wednesday to approve proposed rule changes by three national securities exchanges, enabling them to adopt...
